Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Aptinyx Inc
(NQ:
APTX
)
0.0610
UNCHANGED
Last Price
Updated: 4:00 PM EDT, May 18, 2023
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about Aptinyx Inc
< Previous
1
2
Next >
Aptinyx Completes Enrollment in Phase 2b Study of NYX-2925 in Painful Diabetic Peripheral Neuropathy
October 27, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Report Third Quarter 2021 Financial Results on Tuesday, November 9, 2021
October 25, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Appoints Gilmore O’Neill, M.B., M.M.Sc., to Board of Directors
October 20, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in 2021 Cantor Virtual Global Healthcare Conference
September 20, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Secures $50 Million Growth Capital Credit Facility from K2 HealthVentures
September 16, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in H.C. Wainwright 23rd Annual Global Investment Conference
August 31, 2021
From
Aptinyx Inc.
Via
Business Wire
CORRECTING and REPLACING Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
August 10, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Reports Second Quarter 2021 Financial Results and Business Highlights
August 10, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in 2021 Wedbush PacGrow Healthcare Virtual Conference
August 03, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Report Second Quarter 2021 Financial Results on Tuesday, August 10, 2021
July 26, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in William Blair Biotech Focus Conference 2021
July 12, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in Cowen Psychedelics & Novel Mechanisms in Neuropsychiatry Summit
July 06, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in Upcoming Investor Conferences
June 17, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Provides Update on NYX-783 Development Program for the Treatment of Post-Traumatic Stress Disorder
June 15, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Reports First Quarter 2021 Financial Results and Highlights
May 13, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Appoints Joan W. Miller, M.D. to Board of Directors
May 10, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Report First Quarter 2021 Financial Results on Thursday, May 13, 2021
April 29, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx Presents Additional Positive Data from Phase 2 Exploratory Study of NYX-783 in PTSD at Society of Biological Psychiatry Annual Meeting
April 29, 2021
From
Aptinyx Inc.
Via
Business Wire
Aptinyx to Participate in Upcoming Conferences
April 27, 2021
From
Aptinyx Inc.
Via
Business Wire
< Previous
1
2
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.